TAK-788
TAK-788-3001
Phase 3 small_molecule active
Quick answer
TAK-788 for Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) is a Phase 3 program (small_molecule) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active